Ledger.Open graph →
SEC Form D · Amendment · filed January 24, 2025

Gliknik Inc

Offering
$6.0M
Sold
$5.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Kyle S. Rusconi · Baltimore, MDDirectorPaul A. Friedman · Baltimore, MDDirectorDavid S. Block · Baltimore, MDExec · DirectorRichard S. Levy · Baltimore, MDDirectorRaymond S. Schinazi · Baltimore, MDDirectorCharles S. Polsky · Baltimore, MDDirectorElizabeth C. Block · Baltimore, MDExecDavid C. Broser · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗